About 12,960 results

ALLMedicine™ Urinary Tract Infections Center

Research & Reviews  3,355 results

A Clinical Nurse Specialist-Led Initiative to Reduce Catheter-Associated Urinary Tract ...
https://doi.org/10.1097/NUR.0000000000000643 10.1136/bmjqs-2012-001774 10.1086/675718 10.12788/jhm.2724 10.1016/j.ajic.2014.12.006 10.1097//JN. 0000000000000365 10.1016/j.ajic.2018.01.015
Clinical Nurse Specialist CNS; Pajerski DM, Harlan MD et. al.

Nov 30th, 2021 - The purpose of this clinical nurse specialist-led initiative was to reduce catheter-associated urinary tract infection rates to less than 1 infection per 1000 catheter days, to reduce catheter device utilization, and to improve staff adherence to ...

Persistent Anhydramnios and LUTO in a Patient with a Vesicoamniotic Shunt.
Urology Hannallah A, Baker Z et. al.

Nov 30th, 2021 - Persistent anhydramnios after placement of a vesicoamniotic shunt is a rare but potentially serious concern in a patient in utero. We present the case a male fetus who at 32 weeks gestation had bilateral hydroureteronephrosis, a distended bladder,...

Clinical effectiveness and bacteriological eradication of three different Short-COurse ...
BMJ Open; Garcia-Sangenís A, Morros R et. al.

Nov 27th, 2021 - Uncomplicated lower urinary tract infections (uLUTI) are a common problem in primary care. Current local guidelines recommend the use of a single 3 g dose of fosfomycin. However, most general practitioners (GP) prefer short-course therapies to sin...

Multicentre prospective observational study of sodium-glucose cotransporter-2 inhibitor...
BMJ Open; Seki H, Kuratani N et. al.

Nov 25th, 2021 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antihyperglycaemic agents that promote urinary glucose excretion in the renal proximal tubule and have cardio-protective and renal-protective properties. However, there are sever...

Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected ...
BMC Infectious Diseases; Abongomera G, Koller M et. al.

Nov 25th, 2021 - Antimicrobial drug resistance is one of the top ten threats to global health according to the World Health Organization. Urinary tract infections (UTIs) are among the most common bacterial infections and main reason for antibiotic prescription. Th...

see more →

Guidelines  13 results

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice ...
Annals of Internal Medicine; Lee RA, Centor RM et. al.

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

ACR Appropriateness Criteria® Recurrent Lower Urinary Tract Infections in Females.
Journal of the American College of Radiology : JACR; , Venkatesan AM et. al.

Nov 7th, 2020 - Urinary tract infections (UTIs) in women are common, with an overall lifetime risk over >50%. UTIs are considered recurrent when they follow complete clinical resolution of a previous UTI and are usually defined as at least three episodes of infec...

Committee Opinion No. 717: Sulfonamides, Nitrofurantoin, and Risk of Birth Defects.
Obstetrics and Gynecology;

Aug 24th, 2017 - The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed. As with all patients, antibiotics should be prescribed for pregnant women only for appropriate indications and for the ...

Design and Methodological Considerations of the Centers for Disease Control and Prevent...
The Journal of Urology; Routh JC, Cheng EY et. al.

Oct 25th, 2016 - Care of children with spina bifida has significantly advanced in the last half century, resulting in gains in longevity and quality of life for affected children and caregivers. Bladder dysfunction is the norm in patients with spina bifida and may...

Committee opinion: onabotulinumtoxinA and the bladder.
Female Pelvic Medicine & Reconstructive Surgery;

Sep 3rd, 2014 - In January 2013, the US Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatment option for women. Symptoms of overactive bladder have bee...

see more →

Drugs  986 results see all →

Clinicaltrials.gov  147 results

Efficacy of Mictalase® After ThuLEP

Nov 23rd, 2021 - In this single-center, prospective, randomized, open label, phase-III study, patients with indication to Thulium Laser Enucleation of Prostate were enrolled. The report conformed to CONSORT 2010 guidelines. Eligible patients were 1:1 randomized. R...

Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum

Nov 2nd, 2021 - Indonesia's plan for elimination of schistosomiasis by 2025 requires a better understanding of the factors associated with infection, effective epidemiologic monitoring, and optimization of diagnostic and treatment strategies. In settings of low p...

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

Oct 27th, 2021 - This is a prospective, randomized, multicenter, open-label, parallel group, comparative study to determine the efficacy, safety, and tolerability of aztreonam- avibactam (ATM- AVI) versus best available therapy (BAT) in the treatment of hospitaliz...

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Oct 14th, 2021 - To evaluate Estring versus Replens for treatment of atrophic vaginitis in breast cancer survivors on adjuvant aromatase inhibitor therapy. PRIMARY OBJECTIVE 1. To compare improvement of atrophic vaginitis signs and symptoms between women on the va...

Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections

Sep 29th, 2021 - Phase 2, randomised, double-blind,double-dummy study in hospitalised adults with complicated urinary tract infection (cUTI), including acute pyelonephritis.Treatment duration for each cohort was 7 to 14 days. Patients were not permitted to switch ...

see more →

News  652 results

Infectious disease pop quiz: Clinical challenge #2 for the ObGyn
Emily Susan Edwards, MD, Patrick Duff, MD

Nov 19th, 2021 - Which major organisms cause urinary tract infections (UTIs) in women? Continue to the answer.

EMA Panel Backs Uplizna for Neuromyelitis Optica

Nov 15th, 2021 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the immunosuppressant inebilizumab (Uplizna, Horizon Therapeutics) for adults with neuromyelitis optica spectrum disorder ...

Oral Abx Cut Surgical Site Infections in Colorectal Surgeries

Oct 21st, 2021 - Adding oral antibiotics to intravenous antibiotics with or without enema came out on top for reducing surgical site infections (SSIs) in patients undergoing elective colorectal surgeries, a network meta-analysis suggested. In the analysis of 35 ra...

Women With Recurrent UTIs Express Fear, Frustration

Oct 8th, 2021 - Fear of antibiotic overuse and frustration with physicians who prescribe them too freely are key sentiments expressed by women with recurrent urinary tract infections (rUTIs), according to findings from a study involving six focus groups. Dr Victo...

It's Time to Take Action on Quality Improvement Measures

Oct 6th, 2021 - Michael K. Keng, MD Assistant Professor, Medicine Division of Hematology/Oncology University of Virginia Health System Quality improvement is a method for ensuring that all the activities necessary to design, develop, and implement a prod...

see more →

Patient Education  31 results see all →